comprehensive -WSS

comprehensive

author：entertainment 2025-09-29 17:55:02 - browse：98

Boston Scientific headquarters -- Health coverage from STAT — Boston Scientific is growing its urology portfolio with the Axonics acquisition. Steven Senne/AP

Boston Scientific said it will buy Axonics, a device company treating urinary and bowel disorders, on Monday. The deal is worth $3.7 billion.

It’s the first billion-dollar medical device deal of 2024 — a rare occurrence in 2023, which saw just a handful of medtech acquisitions reaching the billion threshold. Boston Scientific said it expects to close the deal in the first half of this year. Axonics’ stock increased by 20% in light of the news; Boston Scientific’s dropped slightly.

Boston Scientific has acquired companies across all medtech sectors in the past year. The device maker bought Apollo Endosurgery, a company selling surgical tools to combat obesity, for $615 million in 2023. In September of 2023, Boston Scientific bought pain relief company Relievant for $850 million.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： 10 reasons why health care startups fail

explore

WSS

Philips to halt sales of sleep apnea machines in U.S.

Wegovy leads to weight loss. Can it treat depression, too?

Telehealth options flood the market as retailers push virtual care

Traditional Chinese medicine benefits explored in new JAMA study

Venture capital firm's plans to take over Akron hospital face hurdles

Traditional Chinese medicine benefits explored in new JAMA study

entertainment

comprehensive

explore

Cancer drug shortages should be causing more outrage

Philips to halt sales of sleep apnea machines in U.S.

Medical records are filled with copy

Venture capital firm's plans to take over Akron hospital face hurdles

Cancer drug shortages should be causing more outrage

Medicare drug price negotiation legal challenge met with skepticism

New air purifier tech could be key to improving indoor air quality

Readout Newsletter: New research from Sanofi, Regeneron, etc.

Continuity nursing helped my family in our darkest PICU moments

Zyn nicotine pouches become unlikely player in latest culture war

hotspot

Biogen walks away from Aduhelm, years after polarizing approval

Reconstructing family trees of blood cells may help predict disease

Bernie Sanders is gearing up to subpoena pharma CEOs

The pink breast cancer awareness ribbon needs a redesign

Medtronic CEO on promising devices for diabetes, hypertension

How generative AI ratchets up security threats for health systems

entertainment

explore

knowledge

focus